One in two patients ‘safely quit’ T2DM meds after bariatric surgery
Findings 'bode well' for long-term diabetes remission, say Australian researchers.
Half of patients with morbid obesity and type 2 diabetes safely discontinue diabetes treatment within a year of bariatric surgery, Australian research suggests.
Among patients who still required insulin therapy after a year, the average daily dose was reduced by 73% — from 120 units to 32 units a day.
